Neuroone Medical Technologies Corp's ability to collect accounts receivable sequentially worsen to 7.85, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Neuroone Medical Technologies's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 46 days, from 30 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 267 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 1374 to 1868.

What is Receivable Turnover Ratio?
What is Neuroone Medical Technologies Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NMTC Receivables Turnover Ratio	(Mar 31 2026) II. Quarter	(Dec 31 2025) I. Quarter	(Sep 30 2025) IV. Quarter	(Jun 30 2025) III. Quarter	(Mar 31 2025) II. Quarter
Y / Y Receivable Change	661.19 %	616.2 %	208.08 %	-	-
Y / Y Revenue Change	72.46 %	-11.65 %	231.92 %	23.14 %	41.82 %
Receivable Turnover Ratio (TTM)	7.85	12.24	20.67	31.71	18.78
NMTC's Total Ranking	# 1868	# 1374	# 714	# 656	# 544
Accounts Receivable average collection period days	47	30	18	12	19
Seq. Receivable Change	91.85 %	0 %	-	-	80.51 %
Seq. Revenue Change	-17.34 %	5.53 %	61.61 %	22.32 %	-57.65 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 99
Healthcare Sector	# 268
Overall Market	# 1868

Receivable Turnover Ratio Statistics
High	Average	Low
1768.66	289.59	6.1
(Jun 30 2022)		(Dec 31 2022)

NMTC Company Profile • Back to NMTC Efficiency Comparisons • Compare NMTC Receivables Turnover Ratio to its Competitors

Financial Statements
Neuroone Medical Technologies's Accounts Receivable	$ 2 Millions	Visit NMTC's Balance sheet
Neuroone Medical Technologies's Sales TTM	$ 10 Millions	Visit NMTC's Income Statement
Sources of NMTC's Revenues		Visit NMTC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NMTC's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NMTC's Growth Rates	NMTC's Roa	NMTC's Inventory Turnover Ratio	NMTC's Dividend Comparisons
NMTC's Profitability Ratios	NMTC's Roi	NMTC's Asset Turnover Ratio	NMTC's Dividend Growth
NMTC's Valuation Ratios	NMTC's Roe	NMTC's Financial Strength Ratios	NMTC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Vireo Growth Inc.	11.01	$ 350.469 Millions	$ 31.834 Millions
Bioaffinity Technologies Inc	10.79	$ 5.660 Millions	$ 0.525 Millions
Vivos Therapeutics Inc	10.73	$ 19.092 Millions	$ 1.779 Millions
Veracyte Inc	10.68	$ 516.183 Millions	$ 48.353 Millions
Immucell Corporation	10.51	$ 29.035 Millions	$ 2.762 Millions
Kestra Medical Technologies Ltd	10.51	$ 93.819 Millions	$ 8.925 Millions
Lifeloc Technologies Inc	10.41	$ 9.044 Millions	$ 0.869 Millions
Monte Rosa Therapeutics Inc	10.39	$ 42.953 Millions	$ 4.136 Millions
International Stem Cell Corporation	10.23	$ 9.286 Millions	$ 0.908 Millions
Pavmed Inc	10.19	$ 0.107 Millions	$ 0.011 Millions
Viemed Healthcare Inc	10.16	$ 286.565 Millions	$ 28.217 Millions
Addus Homecare Corp	10.14	$ 1,447.070 Millions	$ 142.667 Millions
Utah Medical Products Inc	10.13	$ 36.745 Millions	$ 3.629 Millions
Petvivo Holdings Inc	10.10	$ 0.821 Millions	$ 0.081 Millions
Irhythm Holdings Inc	10.00	$ 787.387 Millions	$ 78.720 Millions
C4 Therapeutics Inc	9.97	$ 34.861 Millions	$ 3.496 Millions
Biodesix Inc	9.94	$ 96.096 Millions	$ 9.665 Millions
Radnet Inc	9.87	$ 2,144.442 Millions	$ 217.223 Millions
Lensar Inc	9.87	$ 57.704 Millions	$ 5.847 Millions
X4 Pharmaceuticals Inc	9.69	$ 9.014 Millions	$ 0.931 Millions
Septerna Inc	9.64	$ 72.255 Millions	$ 7.499 Millions
Encompass Health Corporation	9.63	$ 6,066.400 Millions	$ 629.625 Millions
Biolife Solutions Inc	9.51	$ 99.673 Millions	$ 10.478 Millions
Biofrontera Inc	9.49	$ 42.983 Millions	$ 4.530 Millions
United Therapeutics Corporation	9.47	$ 3,169.800 Millions	$ 334.800 Millions
Tandem Diabetes Care Inc	9.34	$ 1,023.420 Millions	$ 109.550 Millions
Sunshine Biopharma Inc	9.33	$ 35.493 Millions	$ 3.804 Millions
The Oncology Institute Inc	9.30	$ 545.764 Millions	$ 58.671 Millions
The Pennant Group Inc	9.28	$ 1,023.227 Millions	$ 110.305 Millions
Volitionrx Limited	9.23	$ 2.466 Millions	$ 0.267 Millions

Date modified: 2026-09-03T12:03:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.